Informação sobre produto
- (2S)-2-({(2R)-3-(biphenyl-4-yl)-2-[(3,5-dimethylbenzoyl)(methyl)amino]propanoyl}amino)-3-(1H-indol-3-yl)propanoic acid (non-preferred name)
IRL-2500 is a pharmacological agent that binds to the 2-aminoethoxydiphenyl borate (2-APB) site of the receptor for Nerve Growth Factor (NGF). This binding prevents the release of NGF and blocks its effects on neuronal death. IRL-2500 has been shown to have neurotrophic activity in humans, as it stimulates the production of brain-derived neurotrophic factor, which is important for neuronal survival. It also has pressor properties, which may be due to its ability to stimulate production of endothelin and nitric oxide. IRL-2500 has been used in the treatment of congestive heart failure and subarachnoid hemorrhage.
Propriedades químicas
Consulta técnica sobre: 3D-UGA54527 IRL-2500
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
